Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.
Boissel, Nicolas
Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. [electronic resource] - Blood Mar 2011 - 3696-7 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2010-11-320937 doi
Clinical Trials as Topic
Cytogenetic Analysis
Diagnosis, Differential
Genetic Testing
Humans
Isocitrate Dehydrogenase--genetics
Leukemia, Myeloid, Acute--diagnosis
Mutation--physiology
Prognosis
Survival Analysis
Treatment Outcome
Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. [electronic resource] - Blood Mar 2011 - 3696-7 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2010-11-320937 doi
Clinical Trials as Topic
Cytogenetic Analysis
Diagnosis, Differential
Genetic Testing
Humans
Isocitrate Dehydrogenase--genetics
Leukemia, Myeloid, Acute--diagnosis
Mutation--physiology
Prognosis
Survival Analysis
Treatment Outcome